Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2021
Breaking Barriers: Addressing Issues of Inequality in Trial Enrollment and Clinical Outcomes for Patients With Kidney and Bladder CancerJeannie Hoffman-Censits, Ravindran Kanesvaran, Rick Bangs, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 5, 2023
Equitable Access to Clinical Trials: How Do We Achieve It?Ana Acuña-Villaorduña, Joaquina Celebre Baranda, Jessica Boehmer, et al.
Dermatology Online Journal|June 7, 2022
Impact of an evolving regulatory landscape on skin cancer drug development in the U.SDavid M Miller, Sophia Z Shalhout, Denise Casey, et al.
The Oncologist|August 19, 2018
FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1Lola Fashoyin-Aje, Martha Donoghue, Huanyu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2019
FDA Approval Summary: Palbociclib for Male Patients with Metastatic Breast CancerSuparna Wedam, Lola Fashoyin-Aje, Erik Bloomquist, et al.
Blood|May 4, 2023
Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trialsBindu Kanapuru, Laura L Fernandes, Andrea Baines, et al.
Blood Cancer Discovery|June 28, 2021
Recommendations on eliminating racial disparities in multiple myeloma therapies: a step toward achieving equity in healthcareNicole Gormley, Lola Fashoyin-Aje, Trevan Locke, et al.
The Oncologist|May 11, 2021
FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with SorafenibMay Tun Saung, Lorraine Pelosof, Sandra Casak, et al.
Plos One|February 22, 2023
Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patientsThomas G Biel, Svetlana Petrovskaya, Francesca Mascia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2020
FDA Approval Summary: Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2-positive Early Breast CancerSuparna Wedam, Lola Fashoyin-Aje, Xin Gao, et al.
Pageof 3